Trials / Unknown
UnknownNCT02572765
Evaluation of Splenic Metabolic Activity With 18FDG-PET in Hypertension
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Neuromed IRCCS · Academic / Other
- Sex
- All
- Age
- 30 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the splenic activation in hypertensive patients, as compared to normotensives, using FDG-PET/CT imaging. Moreover, the investigators will investigate whether the splenic metabolic activity relates to the expression of circulating inflammatory proteins (high-sensitivity C-reactive protein \[hsCRP\]), interleukin-1b (IL-1b), tumor necrosis factor-a (TNF-a) or to immune profiles of activated T cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | PET/CT scan | PET/CT scan |
Timeline
- Start date
- 2018-01-02
- Primary completion
- 2022-12-01
- Completion
- 2023-09-01
- First posted
- 2015-10-09
- Last updated
- 2022-04-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02572765. Inclusion in this directory is not an endorsement.